Krystal Biotech (KRYS) Net Income (QoQ) (2017 - 2026)
Krystal Biotech (KRYS) Net Income (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Krystal Biotech | 9.90 Bn | 9.07 Bn | 110.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.86% |
| Dec 31, 2025 | -35.25% |
| Sep 30, 2025 | 106.81% |
| Jun 30, 2025 | 7.39% |
| Mar 31, 2025 | -21.43% |
| Dec 31, 2024 | 67.39% |
| Sep 30, 2024 | 74.52% |
| Jun 30, 2024 | 1,570.39% |
| Mar 31, 2024 | -89.28% |
| Dec 31, 2023 | -89.24% |
| Sep 30, 2023 | 343.14% |
| Jun 30, 2023 | 70.95% |
| Mar 31, 2023 | -235.98% |
| Dec 31, 2022 | 50.40% |
| Sep 30, 2022 | -19.41% |
| Jun 30, 2022 | 29.62% |
| Mar 31, 2022 | -270.58% |
| Dec 31, 2021 | 12.25% |
| Sep 30, 2021 | 36.06% |
| Jun 30, 2021 | 12.38% |